Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Feb;43(2):161-71.
doi: 10.1016/j.jpainsymman.2011.04.007. Epub 2011 Sep 17.

Mindfulness-based stress reduction for HIV treatment side effects: a randomized, wait-list controlled trial

Affiliations
Randomized Controlled Trial

Mindfulness-based stress reduction for HIV treatment side effects: a randomized, wait-list controlled trial

Larissa G Duncan et al. J Pain Symptom Manage. 2012 Feb.

Abstract

Context: Advances in antiretroviral therapy (ART) for HIV offer life-extending benefit; however, the side effects associated with ART use negatively impact quality of life and medication adherence among people living with HIV.

Objectives: This study tested the efficacy of Mindfulness-Based Stress Reduction (MBSR) for reducing ART symptoms and bother/distress related to ART side effects. Secondary aims were to test the impact of MBSR on medication adherence and psychological functioning.

Methods: Seventy-six people living with HIV who were actively taking ART and reported distress from ART-related side effects were randomly assigned to an MBSR program or a wait-list control (WLC) standard care condition. We measured side effects, ART adherence, perceived stress, depression, positive and negative affect, and mindfulness at three time points: baseline, three-month follow-up, and six-month follow-up. Side effects and related distress were assessed separately from other symptoms.

Results: Compared with a WLC, participants in the MBSR condition experienced a reduction in the frequency of symptoms attributable to ARTs at three months post-intervention (mean difference=0.33; 95% confidence interval [CI]=0.01, 0.66; t(132)=2.04, P=0.044) and six months post-intervention (mean difference=0.38; 95% CI=0.05, 0.71; t(132)=2.27, P=0.025). MBSR participants also experienced a reduction in distress associated with those symptoms at three months post-intervention (mean difference=0.47; 95% CI=0.003, 0.94; t(132)=1.99, P=0.048) compared with the WLC condition.

Conclusion: MBSR is a promising approach for reducing HIV treatment-related side effects.

PubMed Disclaimer

Conflict of interest statement

Disclosures

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Study flow chart.
Figure 2
Figure 2
Reductions in side effect frequency.
Figure 3
Figure 3
Reductions in side effect bother/distress Note: Sample means are presented above on the original scales of measurement to aid interpretability.

References

    1. Johnson MO, Charlebois E, Morin SF, et al. Perceived adverse effects of antiretroviral therapy. J Pain Symptom Manage. 2005;29:193–205. - PubMed
    1. Volberding PA. HIV therapy in 2003: consensus and controversy. AIDS. 2003;17 Suppl 1:S4–S11. - PubMed
    1. Johnson SC, Gerber JG. Advances in HIV/AIDS therapy. Adv Intern Med. 2000;45(1):1–40. - PubMed
    1. Treisman GJ, Kaplin AI. Neurologic and psychiatric complications of antiretroviral agents. AIDS. 2002;16(9):1201–1215. - PubMed
    1. Chene G, May M, Costagliola D, et al. Prognosis of HIV-1 infected drug naï ve patients starting potent antiretroviral therapy. ART Cohort Collaboration. Paper presented at the XIV International AIDS Conference; Barcelona, Spain. 2002.

Publication types

Substances